Understand how science, health policy, and medicine shape the world everyday. Si...
Want to stay on top of the science and politics driving biotech today? Sign up t...
Bristol Myers agreed to pay $14 billion for Karuna Therapeutics, which has an ex...
Bristol Myers Squibb said Friday that it will acquire Karuna Therapeutics, a dev...
“Every Christmas since my daughter died, I have tried to run away from those mem...
“Family medicine and primary care's obituary has been written many times in my 2...
In the world of infectious diseases and global health, if it’s not one thing, it...
The drug is a monthly injection for a genetic disorder called ATTR-PN, which aff...
Cadonilimab is under clinical development by Akeso and currently in Phase II for...
SOR-007 is under clinical development by Nanology and currently in Phase II for ...
MRNA-2752 is under clinical development by Moderna and currently in Phase I for ...
Imvotamab is under clinical development by IGM Biosciences and currently in Phas...
XB-002 is under clinical development by Exelixis and currently in Phase II for B...
Iruplinalkib is under clinical development by Qilu Pharmaceutical and currently ...
Runimotamab is under clinical development by Genentech USA and currently in Phas...
IDE-161 is under clinical development by Ideaya Biosciences and currently in Pha...